<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36985286</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-2607</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month><Day>09</Day></PubDate></JournalIssue><Title>Microorganisms</Title><ISOAbbreviation>Microorganisms</ISOAbbreviation></Journal><ArticleTitle>Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">713</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/microorganisms11030713</ELocationID><Abstract><AbstractText>The relationship between viral infections and the risk of developing cancer is well known. Multiple mechanisms participate in and determine this process. The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in the deaths of millions of people worldwide. Although the effects of COVID-19 are limited for most people, a large number of people continue to show symptoms for a long period of time (long COVID). Several studies have suggested that cancer could also be a potential long-term complication of the virus; however, the causes of this risk are not yet well understood. In this review, we investigated arguments that could support or reject this possibility.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amiama-Roig</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3326-585X</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica de La Rioja (CIBIR), 26006 Logro&#xf1;o, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>P&#xe9;rez-Mart&#xed;nez</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica de La Rioja (CIBIR), 26006 Logro&#xf1;o, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez Ledo</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Universitario Lucus Augusti, 27003 Lugo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verdugo-Sivianes</LastName><ForeName>Eva M</ForeName><Initials>EM</Initials><Identifier Source="ORCID">0000-0002-0922-0371</Identifier><AffiliationInfo><Affiliation>Instituto de Biomedicina de Sevilla (IBIS), Hospital Universitario Virgen del Roc&#xed;o (HUVR), Consejo Superior de Investigaciones Cient&#xed;ficas, Universidad de Sevilla, 41013 Seville, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco</LastName><ForeName>Jos&#xe9;-Ram&#xf3;n</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-4268-0150</Identifier><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica de La Rioja (CIBIR), 26006 Logro&#xf1;o, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Servicio de Enfermedades Infecciosas, Hospital Universitario San Pedro, 26006 Logro&#xf1;o, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Microorganisms</MedlineTA><NlmUniqueID>101625893</NlmUniqueID><ISSNLinking>2076-2607</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cancer</Keyword><Keyword MajorTopicYN="N">immunosuppression</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">senescence</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>29</Day><Hour>1</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36985286</ArticleId><ArticleId IdType="pmc">PMC10051562</ArticleId><ArticleId IdType="doi">10.3390/microorganisms11030713</ArticleId><ArticleId IdType="pii">microorganisms11030713</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Plummer M., de Martel C., Vignat J., Ferlay J., Bray F., Franceschi S. Global burden of cancers attributable to infections in 2012: A synthetic analysis. Lancet Glob. Health. 2016;4:e609&#x2013;e616. doi: 10.1016/S2214-109X(16)30143-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(16)30143-7</ArticleId><ArticleId IdType="pubmed">27470177</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein M.A., Achong B.G., Barr Y.M. Virus particles in cultured lymphoblasts from Burkitt&#x2019;s lymphoma. Lancet. 1964;1:702&#x2013;703. doi: 10.1016/S0140-6736(64)91524-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(64)91524-7</ArticleId><ArticleId IdType="pubmed">14107961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kellogg C., Kouznetsova V.L., Tsigelny I.F. Implications of viral infection in cancer development. Biochim. Biophys. Acta Rev. Cancer. 2021;1876:188622. doi: 10.1016/j.bbcan.2021.188622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2021.188622</ArticleId><ArticleId IdType="pubmed">34478803</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.J., You S.L., Hsu W.L., Yang H.I., Lee M.H., Chen H.C., Chen Y.Y., Liu J., Hu H.H., Lin Y.J., et al. Epidemiology of virus Infection and human cancer. Recent Results Cancer Res. 2021;217:13&#x2013;45. doi: 10.1007/978-3-030-57362-1_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-030-57362-1_2</ArticleId><ArticleId IdType="pubmed">33200360</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesri E.A., Feitelson M.A., Munger K. Human viral oncogenesis: A cancer hallmarks analysis. Cell Host Microbe. 2014;15:266&#x2013;282. doi: 10.1016/j.chom.2014.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2014.02.011</ArticleId><ArticleId IdType="pmc">PMC3992243</ArticleId><ArticleId IdType="pubmed">24629334</ArticleId></ArticleIdList></Reference><Reference><Citation>Johns Hopkins  Coronavirus Resourse Center.  [(accessed on 29 August 2022)].  Available online:  https://coronavirus.jhu.edu/map.html.</Citation></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Long B., Brady W.J., Koyfman A., Gottlieb M. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 2020;38:1504&#x2013;1507. doi: 10.1016/j.ajem.2020.04.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajem.2020.04.048</ArticleId><ArticleId IdType="pmc">PMC7165109</ArticleId><ArticleId IdType="pubmed">32317203</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Al-Aly Z. Risks and burdens of incident diabetes in long COVID: A cohort study. Lancet Diabetes Endocrinol. 2022;10:311&#x2013;321. doi: 10.1016/S2213-8587(22)00044-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Montori V.M. Patients surviving COVID-19 had increased risk for incident diabetes vs. persons without COVID-19. Ann. Intern. Med. 2022;175:JC93. doi: 10.7326/J22-0052.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/J22-0052</ArticleId><ArticleId IdType="pubmed">35914265</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: A systematic review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Dercon Q., Luciano S., Geddes J.R., Husain M., Harrison P.J. Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Blish C.A., Sallusto F., Iwasaki A. The immunology and immunopathology of COVID-19. Science. 2022;375:1122&#x2013;1127. doi: 10.1126/science.abm8108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs J.J.L. Persistent SARS-2 infections contribute to long COVID-19. Med. Hypotheses. 2021;149:110538. doi: 10.1016/j.mehy.2021.110538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2021.110538</ArticleId><ArticleId IdType="pmc">PMC7884250</ArticleId><ArticleId IdType="pubmed">33621843</ArticleId></ArticleIdList></Reference><Reference><Citation>Acosta-Ampudia Y., Monsalve D.M., Rojas M., Rodriguez Y., Zapata E., Ramirez-Santana C., Anaya J.M. Persistent autoimmune activation and proinflammatory state in Post-Coronavirus Disease 2019 Syndrome. J. Infect. Dis. 2022;225:2155&#x2013;2162. doi: 10.1093/infdis/jiac017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac017</ArticleId><ArticleId IdType="pmc">PMC8903340</ArticleId><ArticleId IdType="pubmed">35079804</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C., Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat. Rev. Rheumatol. 2020;16:413&#x2013;414. doi: 10.1038/s41584-020-0448-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0448-7</ArticleId><ArticleId IdType="pmc">PMC7271827</ArticleId><ArticleId IdType="pubmed">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng K.I., Feng G., Liu W.Y., Targher G., Byrne C.D., Zheng M.H. Extrapulmonary complications of COVID-19: A multisystem disease? J. Med. Virol. 2021;93:323&#x2013;335. doi: 10.1002/jmv.26294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26294</ArticleId><ArticleId IdType="pmc">PMC7405144</ArticleId><ArticleId IdType="pubmed">32648973</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur V., Ratho R.K., Kumar P., Bhatia S.K., Bora I., Mohi G.K., Saxena S.K., Devi M., Yadav D., Mehariya S. Multi-Organ involvement in COVID-19: Beyond pulmonary manifestations. J. Clin. Med. 2021;10:446. doi: 10.3390/jcm10030446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10030446</ArticleId><ArticleId IdType="pmc">PMC7866189</ArticleId><ArticleId IdType="pubmed">33498861</ArticleId></ArticleIdList></Reference><Reference><Citation>Letko M., Marzi A., Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 2020;5:562&#x2013;569. doi: 10.1038/s41564-020-0688-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-020-0688-y</ArticleId><ArticleId IdType="pmc">PMC7095430</ArticleId><ArticleId IdType="pubmed">32094589</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science. 2020;367:1444&#x2013;1448. doi: 10.1126/science.abb2762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2762</ArticleId><ArticleId IdType="pmc">PMC7164635</ArticleId><ArticleId IdType="pubmed">32132184</ArticleId></ArticleIdList></Reference><Reference><Citation>Hikmet F., Mear L., Edvinsson A., Micke P., Uhlen M., Lindskog C. The protein expression profile of ACE2 in human tissues. Mol. Syst. Biol. 2020;16:e9610. doi: 10.15252/msb.20209610.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20209610</ArticleId><ArticleId IdType="pmc">PMC7383091</ArticleId><ArticleId IdType="pubmed">32715618</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugue P.A., Bassett J.K., Wong E.M., Joo J.E., Li S., Yu C., Schmidt D.F., Makalic E., Doo N.W., Buchanan D.D., et al. Biological aging measures based on blood DNA methylation and risk of cancer: A prospective study. JNCI Cancer Spectr. 2021;5:pkaa109. doi: 10.1093/jncics/pkaa109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jncics/pkaa109</ArticleId><ArticleId IdType="pmc">PMC7791618</ArticleId><ArticleId IdType="pubmed">33442664</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorgoulis V., Adams P.D., Alimonti A., Bennett D.C., Bischof O., Bishop C., Campisi J., Collado M., Evangelou K., Ferbeyre G., et al. Cellular senescence: Defining a path forward. Cell. 2019;179:813&#x2013;827. doi: 10.1016/j.cell.2019.10.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.10.005</ArticleId><ArticleId IdType="pubmed">31675495</ArticleId></ArticleIdList></Reference><Reference><Citation>Campisi J., Andersen J.K., Kapahi P., Melov S. Cellular senescence: A link between cancer and age-related degenerative disease? Semin. Cancer Biol. 2011;21:354&#x2013;359. doi: 10.1016/j.semcancer.2011.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcancer.2011.09.001</ArticleId><ArticleId IdType="pmc">PMC3230665</ArticleId><ArticleId IdType="pubmed">21925603</ArticleId></ArticleIdList></Reference><Reference><Citation>Coppe J.P., Patil C.K., Rodier F., Sun Y., Munoz D.P., Goldstein J., Nelson P.S., Desprez P.Y., Campisi J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6:2853&#x2013;2868. doi: 10.1371/journal.pbio.0060301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0060301</ArticleId><ArticleId IdType="pmc">PMC2592359</ArticleId><ArticleId IdType="pubmed">19053174</ArticleId></ArticleIdList></Reference><Reference><Citation>Takasugi M., Okada R., Takahashi A., Virya Chen D., Watanabe S., Hara E. Small extracellular vesicles secreted from senescent cells promote cancer cell proliferation through EphA2. Nat. Commun. 2017;8:15729. doi: 10.1038/ncomms15728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15728</ArticleId><ArticleId IdType="pmc">PMC5467215</ArticleId><ArticleId IdType="pubmed">28585531</ArticleId></ArticleIdList></Reference><Reference><Citation>Fulop T., Dupuis G., Baehl S., Le Page A., Bourgade K., Frost E., Witkowski J.M., Pawelec G., Larbi A., Cunnane S. From inflamm-aging to immune-paralysis: A slippery slope during aging for immune-adaptation. Biogerontology. 2016;17:147&#x2013;157. doi: 10.1007/s10522-015-9615-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-015-9615-7</ArticleId><ArticleId IdType="pubmed">26472173</ArticleId></ArticleIdList></Reference><Reference><Citation>Salminen A. Immunosuppressive network promotes immunosenescence associated with aging and chronic inflammatory conditions. J. Mol. Med. 2021;99:1553&#x2013;1569. doi: 10.1007/s00109-021-02123-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-021-02123-w</ArticleId><ArticleId IdType="pmc">PMC8384586</ArticleId><ArticleId IdType="pubmed">34432073</ArticleId></ArticleIdList></Reference><Reference><Citation>Baz-Martinez M., Da Silva-Alvarez S., Rodriguez E., Guerra J., El Motiam A., Vidal A., Garcia-Caballero T., Gonzalez-Barcia M., Sanchez L., Munoz-Fontela C., et al. Cell senescence is an antiviral defense mechanism. Sci. Rep. 2016;6:37007. doi: 10.1038/srep37007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep37007</ArticleId><ArticleId IdType="pmc">PMC5111111</ArticleId><ArticleId IdType="pubmed">27849057</ArticleId></ArticleIdList></Reference><Reference><Citation>Seoane R., Vidal S., Bouzaher Y.H., El Motiam A., Rivas C. The interaction of viruses with the cellular senescence response. Biology. 2020;9:455. doi: 10.3390/biology9120455.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology9120455</ArticleId><ArticleId IdType="pmc">PMC7764305</ArticleId><ArticleId IdType="pubmed">33317104</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddel R.R. Senescence: An antiviral defense that is tumor suppressive? Carcinogenesis. 2010;31:19&#x2013;26. doi: 10.1093/carcin/bgp274.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgp274</ArticleId><ArticleId IdType="pubmed">19887513</ArticleId></ArticleIdList></Reference><Reference><Citation>Camell C.D., Yousefzadeh M.J., Zhu Y., Prata L., Huggins M.A., Pierson M., Zhang L., O&#x2019;Kelly R.D., Pirtskhalava T., Xun P., et al. Senolytics reduce coronavirus-related mortality in old mice. Science. 2021;373 doi: 10.1126/science.abe4832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abe4832</ArticleId><ArticleId IdType="pmc">PMC8607935</ArticleId><ArticleId IdType="pubmed">34103349</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi U., Nchioua R., Prata L., Zhu Y., Gerdes E.O.W., Giorgadze N., Pirtskhalava T., Parker E., Xue A., Espindola-Netto J.M., et al. SARS-CoV-2 causes senescence in human cells and exacerbates the senescence-associated secretory phenotype through TLR-3. Aging. 2021;13:21838&#x2013;21854. doi: 10.18632/aging.203560.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203560</ArticleId><ArticleId IdType="pmc">PMC8507266</ArticleId><ArticleId IdType="pubmed">34531331</ArticleId></ArticleIdList></Reference><Reference><Citation>Evangelou K., Veroutis D., Paschalaki K., Foukas P.G., Lagopati N., Dimitriou M., Papaspyropoulos A., Konda B., Hazapis O., Polyzou A., et al. Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: Possible implications for viral mutagenesis. Eur. Respir. J. 2022;60:2102951. doi: 10.1183/13993003.02951-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.02951-2021</ArticleId><ArticleId IdType="pmc">PMC8796696</ArticleId><ArticleId IdType="pubmed">35086840</ArticleId></ArticleIdList></Reference><Reference><Citation>Balnis J., Madrid A., Hogan K.J., Drake L.A., Adhikari A., Vancavage R., Singer H.A., Alisch R.S., Jaitovich A. Persistent blood DNA methylation changes one year after SARS-CoV-2 infection. Clin. Epigenetics. 2022;14:94. doi: 10.1186/s13148-022-01313-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-022-01313-8</ArticleId><ArticleId IdType="pmc">PMC9308917</ArticleId><ArticleId IdType="pubmed">35871090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mongelli A., Barbi V., Gottardi Zamperla M., Atlante S., Forleo L., Nesta M., Massetti M., Pontecorvi A., Nanni S., Farsetti A., et al. Evidence for biological age acceleration and telomere shortening in COVID-19 survivors. Int. J. Mol. Sci. 2021;22:6151. doi: 10.3390/ijms22116151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22116151</ArticleId><ArticleId IdType="pmc">PMC8201243</ArticleId><ArticleId IdType="pubmed">34200325</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao X., Li W., Wang T., Ran D., Davalos V., Planas-Serra L., Pujol A., Esteller M., Wang X., Yu H. Accelerated biological aging in COVID-19 patients. Nat. Commun. 2022;13:2135. doi: 10.1038/s41467-022-29801-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29801-8</ArticleId><ArticleId IdType="pmc">PMC9018863</ArticleId><ArticleId IdType="pubmed">35440567</ArticleId></ArticleIdList></Reference><Reference><Citation>Victor J., Deutsch J., Whitaker A., Lamkin E.N., March A., Zhou P., Botten J.W., Chatterjee N. SARS-CoV-2 triggers DNA damage response in Vero E6 cells. Biochem. Biophys. Res. Commun. 2021;579:141&#x2013;145. doi: 10.1016/j.bbrc.2021.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.09.024</ArticleId><ArticleId IdType="pmc">PMC8440005</ArticleId><ArticleId IdType="pubmed">34600299</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzen J., Nuchtern S., Tharmapalan V., Vieri M., Nikolic M., Han Y., Balfanz P., Marx N., Dreher M., Brummendorf T.H., et al. Epigenetic clocks are not accelerated in COVID-19 patients. Int. J. Mol. Sci. 2021;22:9306. doi: 10.3390/ijms22179306.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179306</ArticleId><ArticleId IdType="pmc">PMC8431654</ArticleId><ArticleId IdType="pubmed">34502212</ArticleId></ArticleIdList></Reference><Reference><Citation>Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431&#x2013;436. doi: 10.1038/nature04870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04870</ArticleId><ArticleId IdType="pubmed">16724054</ArticleId></ArticleIdList></Reference><Reference><Citation>Woller N., Kuhnel F. Virus infection, inflammation and prevention of cancer. Recent Results Cancer Res. 2014;193:33&#x2013;58. doi: 10.1007/978-3-642-38965-8_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-642-38965-8_3</ArticleId><ArticleId IdType="pubmed">24008292</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato Y., Takahashi S., Kinouchi Y., Shiraki M., Endo K., Matsumura Y., Kakuta Y., Tosa M., Motida A., Abe H., et al. IL-10 deficiency leads to somatic mutations in a model of IBD. Carcinogenesis. 2006;27:1068&#x2013;1073. doi: 10.1093/carcin/bgi327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgi327</ArticleId><ArticleId IdType="pubmed">16407368</ArticleId></ArticleIdList></Reference><Reference><Citation>Doykov I., Hallqvist J., Gilmour K.C., Grandjean L., Mills K., Heywood W.E. &#x2018;The long tail of Covid-19&#x2019;&#x2014;The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients. F1000Research. 2020;9:1349. doi: 10.12688/f1000research.27287.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.27287.2</ArticleId><ArticleId IdType="pmc">PMC7745182</ArticleId><ArticleId IdType="pubmed">33391730</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieminska I., Weglarczyk K., Surmiak M., Kurowska-Baran D., Sanak M., Siedlar M., Baran J. Mild and asymptomatic COVID-19 convalescents present long-term endotype of immunosuppression associated with neutrophil subsets possessing regulatory functions. Front. Immunol. 2021;12:748097. doi: 10.3389/fimmu.2021.748097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.748097</ArticleId><ArticleId IdType="pmc">PMC8511487</ArticleId><ArticleId IdType="pubmed">34659245</ArticleId></ArticleIdList></Reference><Reference><Citation>Queiroz M.A.F., Neves P., Lima S.S., Lopes J.D.C., Torres M., Vallinoto I., Bichara C.D.A., Dos Santos E.F., de Brito M., da Silva A.L.S., et al. Cytokine profiles associated with acute COVID-19 and long COVID-19 syndrome. Front. Cell. Infect. Microbiol. 2022;12:922422. doi: 10.3389/fcimb.2022.922422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.922422</ArticleId><ArticleId IdType="pmc">PMC9279918</ArticleId><ArticleId IdType="pubmed">35846757</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson D.E., O&#x2019;Keefe R.A., Grandis J.R. Targeting the IL-6/JAK/STAT3 signalling axis in cancer. Nat. Rev. Clin. Oncol. 2018;15:234&#x2013;248. doi: 10.1038/nrclinonc.2018.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrclinonc.2018.8</ArticleId><ArticleId IdType="pmc">PMC5858971</ArticleId><ArticleId IdType="pubmed">29405201</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrhofer J., Graninger M., Lettenmaier L., Schweighardt J., Gentile S.A., Koidl L., Ret D., Stingl M., Puchhammer-Stockl E., Untersmayr E. Association between Epstein-Barr-Virus reactivation and development of Long-COVID fatigue. Allergy. 2022;78:297&#x2013;299. doi: 10.1111/all.15471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.15471</ArticleId><ArticleId IdType="pmc">PMC9538037</ArticleId><ArticleId IdType="pubmed">35950630</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatto I., Biagioni E., Coloretti I., Farinelli C., Avoni C., Caciagli V., Busani S., Sarti M., Pecorari M., Gennari W., et al. Cytomegalovirus blood reactivation in COVID-19 critically ill patients: Risk factors and impact on mortality. Intensive Care Med. 2022;48:706&#x2013;713. doi: 10.1007/s00134-022-06716-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-022-06716-y</ArticleId><ArticleId IdType="pmc">PMC9116062</ArticleId><ArticleId IdType="pubmed">35583676</ArticleId></ArticleIdList></Reference><Reference><Citation>Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783&#x2013;801. doi: 10.1016/j.cell.2006.02.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.02.015</ArticleId><ArticleId IdType="pubmed">16497588</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelemans T., Kikkert M. Viral Innate Immune Evasion and the Pathogenesis of Emerging RNA Virus Infections. Viruses. 2019;11:961. doi: 10.3390/v11100961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11100961</ArticleId><ArticleId IdType="pmc">PMC6832425</ArticleId><ArticleId IdType="pubmed">31635238</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutard B., Valle C., de Lamballerie X., Canard B., Seidah N.G., Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antivir. Res. 2020;176:104742. doi: 10.1016/j.antiviral.2020.104742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2020.104742</ArticleId><ArticleId IdType="pmc">PMC7114094</ArticleId><ArticleId IdType="pubmed">32057769</ArticleId></ArticleIdList></Reference><Reference><Citation>Swanson K.V., Deng M., Ting J.P. The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nat. Rev. Immunol. 2019;19:477&#x2013;489. doi: 10.1038/s41577-019-0165-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-019-0165-0</ArticleId><ArticleId IdType="pmc">PMC7807242</ArticleId><ArticleId IdType="pubmed">31036962</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao C., Zhao W. NLRP3 Inflammasome-A Key Player in Antiviral Responses. Front. Immunol. 2020;11:211. doi: 10.3389/fimmu.2020.00211.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00211</ArticleId><ArticleId IdType="pmc">PMC7040071</ArticleId><ArticleId IdType="pubmed">32133002</ArticleId></ArticleIdList></Reference><Reference><Citation>Albornoz E.A., Amarilla A.A., Modhiran N., Parker S., Li X.X., Wijesundara D.K., Aguado J., Pliego Zamora A., McMillan C.L.D., Liang B., et al. SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. Mol. Psychiatry. 2022 doi: 10.1038/s41380-022-01831-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01831-0</ArticleId><ArticleId IdType="pmc">PMC10615762</ArticleId><ArticleId IdType="pubmed">36316366</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000;908:244&#x2013;254. doi: 10.1111/j.1749-6632.2000.tb06651.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2000.tb06651.x</ArticleId><ArticleId IdType="pubmed">10911963</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L., Fabbri E. Inflammageing: Chronic inflammation in ageing, cardiovascular disease, and frailty. Nat. Rev. Cardiol. 2018;15:505&#x2013;522. doi: 10.1038/s41569-018-0064-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-018-0064-2</ArticleId><ArticleId IdType="pmc">PMC6146930</ArticleId><ArticleId IdType="pubmed">30065258</ArticleId></ArticleIdList></Reference><Reference><Citation>Randall R.E., Griffin D.E. Within host RNA virus persistence: Mechanisms and consequences. Curr. Opin. Virol. 2017;23:35&#x2013;42. doi: 10.1016/j.coviro.2017.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2017.03.001</ArticleId><ArticleId IdType="pmc">PMC5474179</ArticleId><ArticleId IdType="pubmed">28319790</ArticleId></ArticleIdList></Reference><Reference><Citation>Farazi P.A., DePinho R.A. Hepatocellular carcinoma pathogenesis: From genes to environment. Nat. Rev. Cancer. 2006;6:674&#x2013;687. doi: 10.1038/nrc1934.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc1934</ArticleId><ArticleId IdType="pubmed">16929323</ArticleId></ArticleIdList></Reference><Reference><Citation>Isaguliants M., Bayurova E., Avdoshina D., Kondrashova A., Chiodi F., Palefsky J.M. Oncogenic Effects of HIV-1 Proteins, Mechanisms Behind. Cancers. 2021;13:305. doi: 10.3390/cancers13020305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13020305</ArticleId><ArticleId IdType="pmc">PMC7830613</ArticleId><ArticleId IdType="pubmed">33467638</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung C.C.L., Goh D., Lim X., Tien T.Z., Lim J.C.T., Lee J.N., Tan B., Tay Z.E.A., Wan W.Y., Chen E.X., et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut. 2022;71:226&#x2013;229. doi: 10.1136/gutjnl-2021-324280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-324280</ArticleId><ArticleId IdType="pubmed">34083386</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A., Zlitni S., Brooks E.F., Vance S.E., Dahlen A., Hedlin H., Park R.M., Han A., Schmidtke D.T., Verma R., et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022;3:371&#x2013;387.e379. doi: 10.1016/j.medj.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.medj.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9005383</ArticleId><ArticleId IdType="pubmed">35434682</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Wu X., Wen W., Lan P. Gut microbiome alterations in COVID-19. Genom. Proteom. Bioinform. 2021;19:679&#x2013;688. doi: 10.1016/j.gpb.2021.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gpb.2021.09.004</ArticleId><ArticleId IdType="pmc">PMC8478109</ArticleId><ArticleId IdType="pubmed">34560321</ArticleId></ArticleIdList></Reference><Reference><Citation>Verrienti P., Cito G., Di Maida F., Tellini R., Cocci A., Minervini A., Natali A. The impact of COVID-19 on the male genital tract: A qualitative literature review of sexual transmission and fertility implications. Clin. Exp. Reprod. Med. 2022;49:9&#x2013;15. doi: 10.5653/cerm.2021.04511.</Citation><ArticleIdList><ArticleId IdType="doi">10.5653/cerm.2021.04511</ArticleId><ArticleId IdType="pmc">PMC8923629</ArticleId><ArticleId IdType="pubmed">35255654</ArticleId></ArticleIdList></Reference><Reference><Citation>Kresch E., Achua J., Saltzman R., Khodamoradi K., Arora H., Ibrahim E., Kryvenko O.N., Almeida V.W., Firdaus F., Hare J.M., et al. COVID-19 endothelial dysfunction can cause erectile dysfunction: Histopathological, immunohistochemical, and ultrastructural study of the human penis. World J. Mens. Health. 2021;39:466&#x2013;469. doi: 10.5534/wjmh.210055.</Citation><ArticleIdList><ArticleId IdType="doi">10.5534/wjmh.210055</ArticleId><ArticleId IdType="pmc">PMC8255400</ArticleId><ArticleId IdType="pubmed">33988001</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F., Xiao X., Guo J., Song Y., Li H., Patel D.P., Spivak A.M., Alukal J.P., Zhang X., Xiong C., et al. No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil. Steril. 2020;113:1135&#x2013;1139. doi: 10.1016/j.fertnstert.2020.04.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fertnstert.2020.04.024</ArticleId><ArticleId IdType="pmc">PMC7164916</ArticleId><ArticleId IdType="pubmed">32482249</ArticleId></ArticleIdList></Reference><Reference><Citation>Zollner A., Koch R., Jukic A., Pfister A., Meyer M., Rossler A., Kimpel J., Adolph T.E., Tilg H. Postacute COVID-19 is Characterized by Gut Viral Antigen Persistence in Inflammatory Bowel Diseases. Gastroenterology. 2022;163:495&#x2013;506.e498. doi: 10.1053/j.gastro.2022.04.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2022.04.037</ArticleId><ArticleId IdType="pmc">PMC9057012</ArticleId><ArticleId IdType="pubmed">35508284</ArticleId></ArticleIdList></Reference><Reference><Citation>Goh D., Lim J.C.T., Fernaindez S.B., Joseph C.R., Edwards S.G., Neo Z.W., Lee J.N., Caballero S.G., Lau M.C., Yeong J.P.S. Case report: Persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID. Front. Immunol. 2022;13:939989. doi: 10.3389/fimmu.2022.939989.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.939989</ArticleId><ArticleId IdType="pmc">PMC9483160</ArticleId><ArticleId IdType="pubmed">36131932</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R., Zentilin L., Correa R., Colliva A., Silvestri F., Zacchigna S., Collesi C., Giacca M. Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19. J. Pathol. 2023;259:254&#x2013;263. doi: 10.1002/path.6035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.6035</ArticleId><ArticleId IdType="pmc">PMC10107739</ArticleId><ArticleId IdType="pubmed">36651103</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso M.J., Anglin K., Durstenfeld M.S., Martin J.N., Kelly J.D., Hsue P.Y., Henrich T.J., Deeks S.G. Effect of oral nirmatrelvir on Long COVID symptoms: 4 cases and rationale for systematic studies. Pathog. Immun. 2022;7:95&#x2013;103. doi: 10.20411/pai.v7i1.518.</Citation><ArticleIdList><ArticleId IdType="doi">10.20411/pai.v7i1.518</ArticleId><ArticleId IdType="pmc">PMC9254867</ArticleId><ArticleId IdType="pubmed">35800257</ArticleId></ArticleIdList></Reference><Reference><Citation>Owen D.R., Allerton C.M.N., Anderson A.S., Aschenbrenner L., Avery M., Berritt S., Boras B., Cardin R.D., Carlo A., Coffman K.J., et al. An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19. Science. 2021;374:1586&#x2013;1593. doi: 10.1126/science.abl4784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abl4784</ArticleId><ArticleId IdType="pubmed">34726479</ArticleId></ArticleIdList></Reference><Reference><Citation>Briggs E., Ward W., Rey S., Law D., Nelson K., Bois M., Ostrov N., Lee H.H., Laurent J.M., Mita P. Assessment of potential SARS-CoV-2 virus integration into human genome reveals no significant impact on RT-qPCR COVID-19 testing. Proc. Natl. Acad. Sci. USA. 2021;118:e2113065118. doi: 10.1073/pnas.2113065118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113065118</ArticleId><ArticleId IdType="pmc">PMC8612208</ArticleId><ArticleId IdType="pubmed">34702741</ArticleId></ArticleIdList></Reference><Reference><Citation>Parry R., Gifford R.J., Lytras S., Ray S.C., Coin L.J.M. No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues. Proc. Natl. Acad. Sci. USA. 2021;118:e2109066118. doi: 10.1073/pnas.2109066118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2109066118</ArticleId><ArticleId IdType="pmc">PMC8379926</ArticleId><ArticleId IdType="pubmed">34344759</ArticleId></ArticleIdList></Reference><Reference><Citation>Smits N., Rasmussen J., Bodea G.O., Amarilla A.A., Gerdes P., Sanchez-Luque F.J., Ajjikuttira P., Modhiran N., Liang B., Faivre J., et al. No evidence of human genome integration of SARS-CoV-2 found by long-read DNA sequencing. Cell Rep. 2021;36:109530. doi: 10.1016/j.celrep.2021.109530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109530</ArticleId><ArticleId IdType="pmc">PMC8316065</ArticleId><ArticleId IdType="pubmed">34380018</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Richards A., Barrasa M.I., Hughes S.H., Young R.A., Jaenisch R. Reverse-transcribed SARS-CoV-2 RNA can integrate into the genome of cultured human cells and can be expressed in patient-derived tissues. Proc. Natl. Acad. Sci. USA. 2021;118:e2105968118. doi: 10.1073/pnas.2105968118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2105968118</ArticleId><ArticleId IdType="pmc">PMC8166107</ArticleId><ArticleId IdType="pubmed">33958444</ArticleId></ArticleIdList></Reference><Reference><Citation>Craddock V., Mahajan A., Krishnamachary B., Spikes L., Chalise P., Dhillon N.K. Persistent presence of Spike protein and viral RNA in the circulation of individuals with post-acute sequelae of COVID-19. medRxiv. 2022</Citation></Reference><Reference><Citation>Swank Z., Senussi Y., Manickas-Hill Z., Yu X.G., Li J.Z., Alter G., Walt D.R. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin. Infect. Dis. 2022;76:e487&#x2013;e490. doi: 10.1093/cid/ciac722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac722</ArticleId><ArticleId IdType="pmc">PMC10169416</ArticleId><ArticleId IdType="pubmed">36052466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanduc D. From anti-severe acute respiratory syndrome Coronavirus 2 immune response to cancer onset via molecular mimicry and cross-reactivity. Glob. Med. Genet. 2021;8:176&#x2013;182. doi: 10.1055/s-0041-1735590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1735590</ArticleId><ArticleId IdType="pmc">PMC8635832</ArticleId><ArticleId IdType="pubmed">34877576</ArticleId></ArticleIdList></Reference><Reference><Citation>Boulias K., Lieberman J., Greer E.L. An epigenetic clock measures accelerated aging in treated HIV infection. Mol. Cell. 2016;62:153&#x2013;155. doi: 10.1016/j.molcel.2016.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.04.008</ArticleId><ArticleId IdType="pmc">PMC5315270</ArticleId><ArticleId IdType="pubmed">27105110</ArticleId></ArticleIdList></Reference><Reference><Citation>Stingi A., Cirillo L. SARS-CoV-2 infection and cancer: Evidence for and against a role of SARS-CoV-2 in cancer onset. Bioessays. 2021;43:e2000289. doi: 10.1002/bies.202000289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.202000289</ArticleId><ArticleId IdType="pmc">PMC8209829</ArticleId><ArticleId IdType="pubmed">34081334</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardozo C.M., Hainaut P. Viral strategies for circumventing p53: The case of severe acute respiratory syndrome coronavirus. Curr. Opin. Oncol. 2021;33:149&#x2013;158. doi: 10.1097/CCO.0000000000000713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCO.0000000000000713</ArticleId><ArticleId IdType="pmc">PMC7924916</ArticleId><ArticleId IdType="pubmed">33405482</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Carballa A., Martinon-Torres F., Salas A. Is SARS-CoV-2 an oncogenic virus? J. Infect. 2022;85:573&#x2013;607. doi: 10.1016/j.jinf.2022.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.08.005</ArticleId><ArticleId IdType="pmc">PMC9361571</ArticleId><ArticleId IdType="pubmed">35961462</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhart D.L., Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat. Rev. Cancer. 2008;8:671&#x2013;682. doi: 10.1038/nrc2399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc2399</ArticleId><ArticleId IdType="pmc">PMC6996492</ArticleId><ArticleId IdType="pubmed">18650841</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini G., Aneja R. Cancer as a prospective sequela of long COVID-19. Bioessays. 2021;43:e2000331. doi: 10.1002/bies.202000331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.202000331</ArticleId><ArticleId IdType="pmc">PMC8206711</ArticleId><ArticleId IdType="pubmed">33914346</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhardwaj K., Liu P., Leibowitz J.L., Kao C.C. The coronavirus endoribonuclease Nsp15 interacts with retinoblastoma tumor suppressor protein. J. Virol. 2012;86:4294&#x2013;4304. doi: 10.1128/JVI.07012-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.07012-11</ArticleId><ArticleId IdType="pmc">PMC3318636</ArticleId><ArticleId IdType="pubmed">22301153</ArticleId></ArticleIdList></Reference><Reference><Citation>Manning A.L., Longworth M.S., Dyson N.J. Loss of pRB causes centromere dysfunction and chromosomal instability. Genes Dev. 2010;24:1364&#x2013;1376. doi: 10.1101/gad.1917310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1917310</ArticleId><ArticleId IdType="pmc">PMC2895196</ArticleId><ArticleId IdType="pubmed">20551165</ArticleId></ArticleIdList></Reference><Reference><Citation>Surget S., Khoury M.P., Bourdon J.C. Uncovering the role of p53 splice variants in human malignancy: A clinical perspective. OncoTargets Ther. 2013;7:57&#x2013;68. doi: 10.2147/OTT.S53876.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OTT.S53876</ArticleId><ArticleId IdType="pmc">PMC3872270</ArticleId><ArticleId IdType="pubmed">24379683</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi Sadrabadi A., Bereimipour A., Jalili A., Gholipurmalekabadi M., Farhadihosseinabadi B., Seifalian A.M. The risk of pancreatic adenocarcinoma following SARS-CoV family infection. Sci. Rep. 2021;11:12948. doi: 10.1038/s41598-021-92068-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92068-4</ArticleId><ArticleId IdType="pmc">PMC8217230</ArticleId><ArticleId IdType="pubmed">34155232</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X., Wu X., Xiao J., Zhang L., Hao Y., Xiao C., Zhang B., Li J., Jiang X. Are female-specific cancers long-term sequelae of COVID-19? Evidence from a large-scale genome-wide cross-trait analysis. medRxiv. 2022 doi: 10.1101/2022.08.25.22279195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.08.25.22279195</ArticleId><ArticleId IdType="pmc">PMC10450412</ArticleId><ArticleId IdType="pubmed">37636041</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen Q., Wang J., Zhao L. To investigate the internal association between SARS-CoV-2 infections and cancer through bioinformatics. Math. Biosci. Eng. 2022;19:11172&#x2013;11194. doi: 10.3934/mbe.2022521.</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/mbe.2022521</ArticleId><ArticleId IdType="pubmed">36124586</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi E., Changaei M., Teymouri A., Alipour B., Izad M. Cancer Related-Genes Enriched in Peripheral Blood Mononuclear Cells (PBMCs) of COVID-19 Patients. a Bioinformatics Study. Research Square; Durham, NC, USA: 2022.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1894265/v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Casey S.C., Li Y., Felsher D.W. An essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation. Immunol. Res. 2014;58:282&#x2013;291. doi: 10.1007/s12026-014-8503-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-014-8503-6</ArticleId><ArticleId IdType="pmc">PMC4201505</ArticleId><ArticleId IdType="pubmed">24791942</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S., Dellibovi-Ragheb T.A., Kerviel A., Pak E., Qiu Q., Fisher M., Takvorian P.M., Bleck C., Hsu V.W., Fehr A.R., et al. &#x3b2;-Coronaviruses use lysosomes for egress Instead of the biosynthetic secretory pathway. Cell. 2020;183:1520&#x2013;1535.e14. doi: 10.1016/j.cell.2020.10.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.039</ArticleId><ArticleId IdType="pmc">PMC7590812</ArticleId><ArticleId IdType="pubmed">33157038</ArticleId></ArticleIdList></Reference><Reference><Citation>Boumaza A., Gay L., Mezouar S., Bestion E., Diallo A.B., Michel M., Desnues B., Raoult D., La Scola B., Halfon P., et al. Monocytes and macrophages, targets of severe acute respiratory syndrome Coronavirus 2: The clue for Coronavirus Disease 2019 immunoparalysis. J. Infect. Dis. 2021;224:395&#x2013;406. doi: 10.1093/infdis/jiab044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab044</ArticleId><ArticleId IdType="pmc">PMC7928817</ArticleId><ArticleId IdType="pubmed">33493287</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee S., Yu Y., Trimpert J., Benthani F., Mairhofer M., Richter-Pechanska P., Wyler E., Belenki D., Kaltenbrunner S., Pammer M., et al. Virus-induced senescence is a driver and therapeutic target in COVID-19. Nature. 2021;599:283&#x2013;289. doi: 10.1038/s41586-021-03995-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03995-1</ArticleId><ArticleId IdType="pubmed">34517409</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D., Nilsson-Payant B.E., Liu W.C., Uhl S., Hoagland D., Moller R., Jordan T.X., Oishi K., Panis M., Sachs D., et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. 2020;181:1036&#x2013;1045.e1039. doi: 10.1016/j.cell.2020.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Renner D.M., Comar C.E., Whelan J.N., Reyes H.M., Cardenas-Diaz F.L., Truitt R., Tan L.H., Dong B., Alysandratos K.D., et al. SARS-CoV-2 induces double-stranded RNA-mediated innate immune responses in respiratory epithelial-derived cells and cardiomyocytes. Proc. Natl. Acad. Sci. USA. 2021;118:e2022643118. doi: 10.1073/pnas.2022643118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2022643118</ArticleId><ArticleId IdType="pmc">PMC8072330</ArticleId><ArticleId IdType="pubmed">33811184</ArticleId></ArticleIdList></Reference><Reference><Citation>Kee J., Thudium S., Renner D.M., Glastad K., Palozola K., Zhang Z., Li Y., Lan Y., Cesare J., Poleshko A., et al. SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. Nature. 2022;610:381&#x2013;388. doi: 10.1038/s41586-022-05282-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05282-z</ArticleId><ArticleId IdType="pmc">PMC9533993</ArticleId><ArticleId IdType="pubmed">36198800</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarakhovsky A., Prinjha R.K. Drawing on disorder: How viruses use histone mimicry to their advantage. J. Exp. Med. 2018;215:1777&#x2013;1787. doi: 10.1084/jem.20180099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20180099</ArticleId><ArticleId IdType="pmc">PMC6028506</ArticleId><ArticleId IdType="pubmed">29934321</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Donk L.E.H., Eder J., van Hamme J.L., Brouwer P.J.M., Brinkkemper M., van Nuenen A.C., van Gils M.J., Sanders R.W., Kootstra N.A., Bermejo-Jambrin M., et al. SARS-CoV-2 infection activates dendritic cells via cytosolic receptors rather than extracellular TLRs. Eur. J. Immunol. 2002;52:646&#x2013;655. doi: 10.1002/eji.202149656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.202149656</ArticleId><ArticleId IdType="pmc">PMC9015339</ArticleId><ArticleId IdType="pubmed">35099061</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sluis R.M., Cham L.B., Gris-Oliver A., Gammelgaard K.R., Pedersen J.G., Idorn M., Ahmadov U., Hernandez S.S., C&#xe9;malovic E., Godsk S.H., et al. TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection. EMBO J. 2022;41:e109622. doi: 10.15252/embj.2021109622.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2021109622</ArticleId><ArticleId IdType="pmc">PMC9108609</ArticleId><ArticleId IdType="pubmed">35178710</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi J. NK cell dysfunction in patients with COVID-19. Cell Mol. Immunol. 2022;19:127&#x2013;129. doi: 10.1038/s41423-021-00825-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00825-2</ArticleId><ArticleId IdType="pmc">PMC8755515</ArticleId><ArticleId IdType="pubmed">35022604</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernal E., Gimeno L., Alcaraz M.J., Quadeer A.A., Moreno M., Mart&#xed;nez-S&#xe1;nchez M.V., Campillo J.A., Gomez J.M., Pelaez A., Garc&#xed;a E., et al. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019. J. Infect. Dis. 2021;224:229&#x2013;240. doi: 10.1093/infdis/jiab228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab228</ArticleId><ArticleId IdType="pmc">PMC8135764</ArticleId><ArticleId IdType="pubmed">33928374</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajeer A., Jawdat D., Massadeh S., Aljawini N., Abedalthagafi M.S., Arabi Y.M., Alaamery M. Association of KIR gene polymorphisms with COVID-19 disease. Clin. Immunol. 2022;234:108911. doi: 10.1016/j.clim.2021.108911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2021.108911</ArticleId><ArticleId IdType="pmc">PMC8683215</ArticleId><ArticleId IdType="pubmed">34929414</ArticleId></ArticleIdList></Reference><Reference><Citation>De Winter F.H.R., Hotterbeekx A., Huizing M.T., Konnova A., Fransen E., Jongers B., Jairam R.K., Van Averbeke V., Moons P., Roelant E., et al. Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients. Cancers. 2021;13:5718. doi: 10.3390/cancers13225718.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13225718</ArticleId><ArticleId IdType="pmc">PMC8616215</ArticleId><ArticleId IdType="pubmed">34830872</ArticleId></ArticleIdList></Reference><Reference><Citation>Habibzadeh P., Dastsooz H., Eshraghi M., Los M.J., Klionsky D.J., Ghavami S. Autophagy: The potential link between SARS-CoV-2 and cancer. Cancers. 2021;13:5721. doi: 10.3390/cancers13225721.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers13225721</ArticleId><ArticleId IdType="pmc">PMC8616402</ArticleId><ArticleId IdType="pubmed">34830876</ArticleId></ArticleIdList></Reference><Reference><Citation>Challenor S., Tucker D. SARS-CoV-2-induced remission of Hodgkin lymphoma. Br. J. Haematol. 2021;192:415. doi: 10.1111/bjh.17116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17116</ArticleId><ArticleId IdType="pubmed">33386647</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasin F., Mascalchi Calveri M., Calabrese A., Pizzarelli G., Bongiovanni I., Andreoli M., Cattaneo C., Rignanese G. Oncolytic effect of SARS-CoV2 in a patient with NK lymphoma. Acta Biomed. 2020;91 doi: 10.23750/abm.v91i3.10141. ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i3.10141</ArticleId><ArticleId IdType="pmc">PMC7716983</ArticleId><ArticleId IdType="pubmed">32921739</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollini M., Gelardi F., Carlo-Stella C., Chiti A. Complete remission of follicular lymphoma after SARS-CoV-2 infection: From the &#x201c;flare phenomenon&#x201d; to the &#x201c;abscopal effect&#x201d;. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2652&#x2013;2654. doi: 10.1007/s00259-021-05275-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05275-6</ArticleId><ArticleId IdType="pmc">PMC7913037</ArticleId><ArticleId IdType="pubmed">33638660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ottaiano A., Scala S., D&#x2019;Alterio C., Trotta A., Bello A., Rea G., Picone C., Santorsola M., Petrillo A., Nasti G. Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection. Ther. Adv. Med. Oncol. 2021;13:17588359211011455. doi: 10.1177/17588359211011455.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17588359211011455</ArticleId><ArticleId IdType="pmc">PMC8107669</ArticleId><ArticleId IdType="pubmed">33995596</ArticleId></ArticleIdList></Reference><Reference><Citation>Donia A., Shahid R., Nawaz M., Yaqub T., Bokhari H. Can we develop oncolytic SARS-CoV-2 to specifically target cancer cells? Ther. Adv. Med. Oncol. 2021;13:17588359211061988. doi: 10.1177/17588359211061988.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17588359211061988</ArticleId><ArticleId IdType="pmc">PMC8646194</ArticleId><ArticleId IdType="pubmed">34880954</ArticleId></ArticleIdList></Reference><Reference><Citation>Buckner T.W., Dunphy C., Fedoriw Y.D., van Deventer H.W., Foster M.C., Richards K.L., Park S.I. Complete spontaneous remission of diffuse large B-cell lymphoma of the maxillary sinus after concurrent infections. Clin. Lymphoma Myeloma Leuk. 2012;12:455&#x2013;458. doi: 10.1016/j.clml.2012.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clml.2012.06.007</ArticleId><ArticleId IdType="pubmed">23025990</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam M.H., Wing Y.K., Yu M.W., Leung C.M., Ma R.C., Kong A.P., So W.Y., Fong S.Y., Lam S.P. Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: Long-term follow-up. Arch. Intern. Med. 2009;169:2142&#x2013;2147. doi: 10.1001/archinternmed.2009.384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P., Li J., Liu H., Han N., Ju J., Kou Y., Chen L., Jiang M., Pan F., Zheng Y., et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: A 15-year follow-up from a prospective cohort study. Bone Res. 2020;8:8. doi: 10.1038/s41413-020-0084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41413-020-0084-5</ArticleId><ArticleId IdType="pmc">PMC7018717</ArticleId><ArticleId IdType="pubmed">32128276</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen M.B. COVID-19, cancer post-pandemic risk, and the radiation oncology physicist. J. Appl. Clin. Med. Phys. 2022;23:e13628. doi: 10.1002/acm2.13628.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acm2.13628</ArticleId><ArticleId IdType="pmc">PMC9121025</ArticleId><ArticleId IdType="pubmed">35527479</ArticleId></ArticleIdList></Reference><Reference><Citation>Maringe C., Spicer J., Morris M., Purushotham A., Nolte E., Sullivan R., Rachet B., Aggarwal A. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: A national, population-based, modelling study. Lancet Oncol. 2020;21:1023&#x2013;1034. doi: 10.1016/S1470-2045(20)30388-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1470-2045(20)30388-0</ArticleId><ArticleId IdType="pmc">PMC7417808</ArticleId><ArticleId IdType="pubmed">32702310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bian T., Gibbs J.D., &#xd6;rvell C., Imani F. Respiratory syncytial virus matrix protein induces lung epithelial cell cycle arrest through a p53 dependent pathway. PLoS ONE. 2012;8:e38052. doi: 10.1371/journal.pone.0038052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0038052</ArticleId><ArticleId IdType="pmc">PMC3360651</ArticleId><ArticleId IdType="pubmed">22662266</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., Serafini R.A., Pryce K.D., Zazhytska M., Oishi K., Golynker I., Panis M., Zimering J., Horiuchi S., Hoagland D.A., et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations post recovery. Sci. Transl. Med. 2022:eabq3059. doi: 10.1126/scitranslmed.abq3059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abq3059</ArticleId><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>